Scanning laser polarimetry and spectral domain optical coherence tomography for the detection of retinal changes in Parkinson's disease

Acta Ophthalmologica

Volumn 93, Issue 8, 2015, Pages e672-e677

  Stemplewitz, Birthe ^a   Keserü, Matthias ^a   Bittersohl, Diana ^a   Buhmann, Carsten ^a   Skevas, Christos ^a   Richard, Gisbert ^a   Hassenstein, Andrea ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

macular volume; Parkinson's disease; RNFL thickness; scanning laser polarimetry; SD OCT

Indexed keywords

ADULT; ANTERIOR EYE SEGMENT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; EYE DISEASE; EYE REFRACTION; FEMALE; HOEHN AND YAHR SCALE; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPHTHALMOLOGIST; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PARKINSON DISEASE; POLARIMETER; POSTERIOR EYE SEGMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DEGENERATION; RETINA MACULA LUTEA; RETINAL NERVE FIBER LAYER THICKNESS; RETINAL THICKNESS; SCANNING LASER POLARIMETRY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; AGED; MIDDLE AGED; NERVE FIBER; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETINA GANGLION CELL; RETINAL DISEASES;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; NERVE FIBERS; PARKINSON DISEASE; REFRACTION, OCULAR; RETINAL DISEASES; RETINAL GANGLION CELLS; SCANNING LASER POLARIMETRY; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84955639525     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12764     Document Type: Article

References (36)

1. Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, &, Kiss S, (2010): Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol 4: 1427-1432.
2. Albrecht P, Muller AK, Sudmeyer M, et al., (2012): Optical coherence tomography in parkinsonian syndromes. PLoS ONE 7: e34891.
3. Altintas O, Iseri P, Ozkan B, &, Caglar Y, (2008): Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol 116: 137-146.
4. Archibald NK, Clarke MP, Mosimann UP, &, Burn DJ, (2009): The retina in Parkinson's disease. Brain 132: 1128-1145.
5. Archibald NK, Clarke MP, Mosimann UP, &, Burn DJ, (2011): Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord 17: 431-436.
6. Bodis-Wollner I, (2009): Retinopathy in Parkinson disease. J Neural Transm 116: 1493-1501.
7. Bodis-Wollner I, Glazman S, &, Yerram S, (2013): Fovea and foveation in Parkinson's disease. Behav Neurosci 127: 139-150.
8. Bodis-Wollner I, &, Yahr MD, (1978): Measurements of visual evoked potentials in Parkinson's disease. Brain 101: 661-671.
9. Braak H, Del TK, Bratzke H, Hamm-Clement J, Sandmann-Keil D, &, Rub U, (2002): Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249 (Suppl 3): III/1-III/5.
10. Cubo E, Tedejo RP, Rodriguez Mendez V, Lopez Pena MJ, &, Trejo Gabriel YGJM, (2010): Retina thickness in Parkinson's disease and essential tremor. Mov Disord 25: 2461-2462.
11. Dauer W, &, Przedborski S, (2003): Parkinson's disease: mechanisms and models. Neuron 39: 889-909.
12. de Lau LM, &, Breteler MM, (2006): Epidemiology of Parkinson's disease. Lancet Neurol 5: 525-535.
13. Ding Y, Spund B, Glazman S, Shrier EM, Miri S, Selesnick I, &, Bodis-Wollner I, (2014): Application of an OCT data-based mathematical model of the foveal pit in Parkinson disease. J Neural Transm 121: 1367-1376.
14. Frederick JM, Rayborn ME, Laties AM, Lam DM, &, Hollyfield JG, (1982): Dopaminergic neurons in the human retina. J Comp Neurol 210: 65-79.
15. Garcia-Martin E, Satue M, Fuertes I, et al., (2012): Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease. Ophthalmology 119: 2161-2167.
16. Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, &, Bodis-Wollner IG, (2009): Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127: 737-741.
17. Hawkes CH, Del TK, &, Braak H, (2010): A timeline for Parkinson's disease. Parkinsonism Relat Disord 16: 79-84.
18. Hoehn MM, &, Yahr MD, (1967): Parkinsonism: onset, progression and mortality. Neurology 17: 427-442.
19. Inzelberg R, Ramirez JA, Nisipeanu P, &, Ophir A, (2004): Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 44: 2793-2797.
20. La Morgia C, Barboni P, Rizzo G, et al., (2013): Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur J Neurol 20: 198-201.
21. Maass A, &, Reichmann H, (2013): Sleep and non-motor symptoms in Parkinson's disease. J Neural Transm 120: 565-569.
22. Maresca A, la MC, Caporali L, Valentino ML, &, Carelli V, (2013): The optic nerve: a "mito-window" on mitochondrial neurodegeneration. Mol Cell Neurosci 55: 62-76.
23. Moreno-Ramos T, Benito-Leon J, Villarejo A, &, Bermejo-Pareja F, (2013): Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with lewy bodies, and Alzheimer's disease. J Alzheimers Dis 34: 659-664.
24. Patel NB, Lim M, Gajjar A, Evans KB, &, Harwerth RS, (2014): Age-associated changes in the retinal nerve fiber layer and optic nerve head. Invest Ophthalmol Vis Sci 55: 5134-5143.
25. Reader TA, &, Quesney LF, (1986): Dopamine in the visual cortex of the cat. Experientia 42: 1242-1244.
26. Reus NJ, &, Lemij HG, (2004): Diagnostic accuracy of the GDx VCC for glaucoma. Ophthalmology 111: 1860-1865.
27. Roth NM, Saidha S, Zimmermann H, et al., (2014): Photoreceptor layer thinning in idiopathic Parkinson's disease. Mov Disord 29: 1163-1170.
28. Sartucci F, Orlandi G, Lucetti C, Bonuccelli U, Murri L, Orsini C, &, Porciatti V, (2003): Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinson's disease. J Clin Neurophysiol 20: 375-381.
29. Schapira AH, (1994): Evidence for mitochondrial dysfunction in Parkinson's disease-a critical appraisal. Mov Disord 9: 125-138.
30. Schneider M, Muller HP, Lauda F, Tumani H, Ludolph AC, Kassubek J, &, Pinkhardt EH, (2014): Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. J Neural Transm 121: 41-47.
31. Shrier EM, Adam CR, Spund B, Glazman S, &, Bodis-Wollner I, (2012): Interocular asymmetry of foveal thickness in Parkinson disease. J Ophthalmol 2012: 728457.
32. Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, &, Bodis-Wollner I, (2013): Remodeling of the fovea in Parkinson disease. J Neural Transm 120: 745-753.
33. Sung KR, Wollstein G, Bilonick RA, et al., (2009): Effects of age on optical coherence tomography measurements of healthy retinal nerve fiber layer, macula, and optic nerve head. Ophthalmology 116: 1119-1124.
34. Tsironi EE, Dastiridou A, Katsanos A, et al., (2012): Perimetric and retinal nerve fiber layer findings in patients with Parkinson's disease. BMC ophthalmol 12: 54.
35. Weinreb RN, Bowd C, &, Zangwill LM, (2003): Glaucoma detection using scanning laser polarimetry with variable corneal polarization compensation. Arch Ophthalmol 121: 218-224.
36. Zucco G, Zeni MT, Perrone A, &, Piccolo I, (2001): Olfactory sensitivity in early-stage Parkinson patients affected by more marked unilateral disorder. Percept Mot Skills 92: 894-898.